# Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis

> **NCT00432900** · PHASE1 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 21 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **RADIATION:** [(11)C]PBR28

## Key facts

- **NCT ID:** NCT00432900
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02-05
- **Primary completion:** 2013-05-23
- **Final completion:** 2013-05-29
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2019-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00432900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00432900, "Brain Peripheral Benzodiazepine Receptors in Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00432900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
